Q ) Post Whipple's pancreatectomy drain amylase is done on ? (AIIMS ONCO)
a) 1st day
b) 3rd day
c) 5th day
d) Not required
Onco Surgery AIIMS 2019 Q 21-40
Oncosurgery
Coronary vein
Q) Coronary vein is (AIIMS Onco 2019)
Answer is for premium members. Join Premium
Malignant polyp in colon
Q ) Not a malignant polyp in colon (AIIMS Onco)
a) Juvenile polyp
b) Juvenile polyposis syndrome (JPS)
c) Peutz jeghers
d) FAP
Bevacizumab
Q) Not true about use of Bevacizumab
a) It is a humanized monoclonal antibody against VEGF A
b) Bevacizumab is a first-line treatment in metastatic nonsquamous non-small cell lung cancer.
c) Bevacizumab is a first-line or second-line therapy for metastatic colorectal cancer
d) Its major advantage is that it has replaced combination chemotherapy
Correct Answer: d) Its major advantage is that it has replaced combination chemotherapy
Explanation:
a) True – Bevacizumab is a humanized monoclonal antibody targeting vascular endothelial growth factor A (VEGF-A), thereby inhibiting angiogenesis.
b) True – Bevacizumab is used as first-line treatment in combination with chemotherapy for metastatic nonsquamous non-small cell lung cancer (NSCLC).
c) True – Bevacizumab is used as first-line and second-line therapy in combination with chemotherapy for metastatic colorectal cancer.
d) Not true – Bevacizumab is not a replacement for combination chemotherapy. Instead, it is used in combination with standard chemotherapy regimens to improve efficacy. It is not used as a monotherapy in most settings.
Nasopharyngeal carcinoma
Q) Not a true statement about nasopharyngeal Carcinoma?
a) Type III has a better prognosis than Type I
b) It commonly presents with blocked nose and upper neck mass
c) Cranial nerves are commonly involved
d) EBV is a causative agent